1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Extracellular Vesicles Regulate Biofilm Formation and Yeast-to-Hypha Differentiation in Candida albicans

      research-article
      a , a , b , a , a , c , c , d , b , e , f , a , a , g , g , h , i , j , k , j , k , l , m , l , l , n , l , l , b , a ,
      ,
      mBio
      American Society for Microbiology
      biofilm, Candida albicans, extracellular vesicles, lipids, yeast-to-hypha inhibition

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          In this study, we investigated the influence of fungal extracellular vesicles (EVs) during biofilm formation and morphogenesis in Candida albicans. Using crystal violet staining and scanning electron microscopy (SEM), we demonstrated that C. albicans EVs inhibited biofilm formation in vitro. By time-lapse microscopy and SEM, we showed that C. albicans EV treatment stopped filamentation and promoted pseudohyphae formation with multiple budding sites. The ability of C. albicans EVs to regulate dimorphism was further compared to EVs isolated from different C. albicans strains, Saccharomyces cerevisiae, and Histoplasma capsulatum. C. albicans EVs from distinct strains inhibited yeast-to-hyphae differentiation with morphological changes occurring in less than 4 h. EVs from S. cerevisiae and H. capsulatum modestly reduced morphogenesis, and the effect was evident after 24 h of incubation. The inhibitory activity of C. albicans EVs on phase transition was promoted by a combination of lipid compounds, which were identified by gas chromatography-tandem mass spectrometry analysis as sesquiterpenes, diterpenes, and fatty acids. Remarkably, C. albicans EVs were also able to reverse filamentation. Finally, C. albicans cells treated with C. albicans EVs for 24 h lost their capacity to penetrate agar and were avirulent when inoculated into Galleria mellonella. Our results indicate that fungal EVs can regulate yeast-to-hypha differentiation, thereby inhibiting biofilm formation and attenuating virulence.

          Related collections

          Most cited references70

          • Record: found
          • Abstract: found
          • Article: not found

          Candida albicans morphogenesis and host defence: discriminating invasion from colonization.

          Candida albicans is a common fungal pathogen of humans that colonizes the skin and mucosal surfaces of most healthy individuals. Until recently, little was known about the mechanisms by which mucosal antifungal defences tolerate colonizing C. albicans but react strongly when hyphae of the same microorganism attempt to invade tissue. In this Review, we describe the properties of yeast cells and hyphae that are relevant to their interaction with the host, and the immunological mechanisms that differentially recognize colonizing versus invading C. albicans.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

            The inoculum size effect in the dimorphic fungus Candida albicans results from production of an extracellular quorum-sensing molecule (QSM). This molecule prevents mycelial development in both a growth morphology assay and a differentiation assay using three chemically distinct triggers for germ tube formation (GTF): L-proline, N-acetylglucosamine, and serum (either pig or fetal bovine). In all cases, the presence of QSM prevents the yeast-to-mycelium conversion, resulting in actively budding yeasts without influencing cellular growth rates. QSM exhibits general cross-reactivity within C. albicans in that supernatants from strain A72 are active on five other strains of C. albicans and vice versa. The QSM excreted by C. albicans is farnesol (C(15)H(26)O; molecular weight, 222.37). QSM is extracellular, and is produced continuously during growth and over a temperature range from 23 to 43 degrees C, in amounts roughly proportional to the CFU/milliliter. Production is not dependent on the type of carbon source nor nitrogen source or on the chemical nature of the growth medium. Both commercial mixed isomer and (E,E)-farnesol exhibited QSM activity (the ability to prevent GTF) at a level sufficient to account for all the QSM activity present in C. albicans supernatants, i.e., 50% GTF at ca. 30 to 35 microM. Nerolidol was ca. two times less active than farnesol. Neither geraniol (C(10)), geranylgeraniol (C(20)), nor farnesyl pyrophosphate had any QSM activity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.

              The mechanisms by which macromolecules are transported through the cell wall of fungi are not known. A central question in the biology of Cryptococcus neoformans, the causative agent of cryptococcosis, is the mechanism by which capsular polysaccharide synthesized inside the cell is exported to the extracellular environment for capsule assembly and release. We demonstrate that C. neoformans produces extracellular vesicles during in vitro growth and animal infection. Vesicular compartments, which are transferred to the extracellular space by cell wall passage, contain glucuronoxylomannan (GXM), a component of the cryptococcal capsule, and key lipids, such as glucosylceramide and sterols. A correlation between GXM-containing vesicles and capsule expression was observed. The results imply a novel mechanism for the release of the major virulence factor of C. neoformans whereby polysaccharide packaged in lipid vesicles crosses the cell wall and the capsule network to reach the extracellular environment.
                Bookmark

                Author and article information

                Contributors
                Role: Invited Editor
                Role: Editor
                Journal
                mBio
                mBio
                mbio
                mBio
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                2150-7511
                14 April 2022
                May-Jun 2022
                14 April 2022
                : 13
                : 3
                : e00301-22
                Affiliations
                [a ] Laboratório de Glicobiologia de Eucariotos, Departamento de Microbiologia Geral, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                [b ] Department of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, El Paso, Texas, USA
                [c ] Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filhos (IBCCF), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                [d ] LPO-COPEA, Instituto de Ciências Biomédicas & Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                [e ] Laboratório de Citotoxicidade e Genotoxicidade, Departamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                [f ] Laboratório de Bioquímica e Imunologia das Micoses, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, Brazil
                [g ] Department of Microbiology and Immunology, Stony Brook Universitygrid.36425.36, , Stony Brook, New York, USA
                [h ] Department of Microbiology and Immunology and Division of Infectious Diseases, Stony Brook Universitygrid.36425.36, , Stony Brook, New York, USA
                [i ] Veterans Affairs Medical Center, Northport, New York, USA
                [j ] Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
                [k ] Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
                [l ] Instituto Carlos Chagas (ICC), Fundação Oswaldo Cruz (FIOCRUZ), Curitiba, Brazil
                [m ] Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
                [n ] Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                University of Wisconsin—Madison
                Leibniz Institute for Natural Product Research and Infection Biology–Hans Knoell Institute Jena (HKI)
                Author notes
                [*]

                Present address: Maria Tays Mendes, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

                Leandro Honorato and Joana Feital Demetrio de Araujo contributed equally to this work. Author order was determined in agreement between both Co-first authors.

                The authors declare a conflict of interest. Dr. Maurizio Del Poeta, M.D. is a Co-Founder and Chief Scientific Officer (CSO) of MicroRid Technologies Inc.

                Author information
                https://orcid.org/0000-0003-0370-5682
                https://orcid.org/0000-0001-8418-3120
                https://orcid.org/0000-0001-7532-2432
                https://orcid.org/0000-0002-1972-2658
                https://orcid.org/0000-0002-2443-8213
                https://orcid.org/0000-0001-9281-6856
                Article
                00301-22 mbio.00301-22
                10.1128/mbio.00301-22
                9239257
                35420476
                b8171fad-7fd1-4246-a7e2-5d5ef44bea08
                Copyright © 2022 Honorato et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 10 February 2022
                : 9 March 2022
                Page count
                supplementary-material: 0, Figures: 8, Tables: 2, Equations: 0, References: 70, Pages: 21, Words: 14253
                Funding
                Funded by: MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), FundRef https://doi.org/10.13039/501100003593;
                Award ID: 311179/2017-7
                Award ID: 408711/2017-7
                Award Recipient :
                Funded by: Fundação Oswaldo Cruz (FIOCRUZ), FundRef https://doi.org/10.13039/501100006507;
                Award ID: VPPCB-007-FIO-18
                Award ID: VPPIS-001-FIO18
                Award Recipient : Award Recipient :
                Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), FundRef https://doi.org/10.13039/501100002322;
                Award ID: Finance Code 001
                Award Recipient : Award Recipient : Award Recipient :
                Funded by: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), FundRef https://doi.org/10.13039/501100004586;
                Award ID: E-26/202.809/2018
                Award Recipient :
                Funded by: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), FundRef https://doi.org/10.13039/501100004586;
                Award ID: E-26/202.696/2018
                Award Recipient :
                Funded by: HHS | National Institutes of Health (NIH), FundRef https://doi.org/10.13039/100000002;
                Award ID: AI124797
                Award Recipient :
                Funded by: HHS | National Institutes of Health (NIH), FundRef https://doi.org/10.13039/100000002;
                Award ID: AI136934
                Award ID: AI116420
                Award ID: AI125770
                Award Recipient :
                Funded by: Merit Review Grant;
                Award ID: I01BX002924
                Award Recipient :
                Funded by: HHS | NIH | National Institute on Minority Health and Health Disparities (NIMHD), FundRef https://doi.org/10.13039/100006545;
                Award ID: 5U54MD007592
                Award Recipient : Award Recipient :
                Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), FundRef https://doi.org/10.13039/501100002322;
                Award ID: 013622/2013-07
                Award Recipient :
                Categories
                Research Article
                mycology, Mycology
                Custom metadata
                May/June 2022

                Life sciences
                biofilm,candida albicans,extracellular vesicles,lipids,yeast-to-hypha inhibition
                Life sciences
                biofilm, candida albicans, extracellular vesicles, lipids, yeast-to-hypha inhibition

                Comments

                Comment on this article